CBPO [China Biologic Products] SC 13D: (Original Filing)
[JOINT FILING AGREEMENT Execution page follows [ PW MEDTECH GROUP LIMITED Jiang Liwei Executive Director and Chief Executive Officer CROSS MARK LIMITED By Liu Yufeng Director LIU YUFENG By] []
CBPO [China Biologic Products] SC 13D: JOINT FILING AGREEMENT Execution page follows [ PW
[JOINT FILING AGREEMENT Execution page follows [ PW MEDTECH GROUP LIMITED Jiang Liwei Executive Director and Chief Executive Officer CROSS MARK LIMITED By Liu Yufeng Director LIU YUFENG By] []
CBPO [China Biologic Products] 6-K: (Original Filing)
[FOR RELEASE January 8, 2018 China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference BEIJING, China – January 8, 2018 – For additional information or to request a meeting with management, please contact your J.P. Morgan institutional sales representative. About China Biologic Produ]
CBPO [China Biologic Products] 6-K: FOR RELEASE January 8, 2018 China Biologic to
[FOR RELEASE January 8, 2018 China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference BEIJING, China – January 8, 2018 – For additional information or to request a meeting with management, please contact your J.P. Morgan institutional sales representative. About China Biologic Produ]
CBPO [China Biologic Products] 6-K: (Original Filing)
[FOR RELEASE January 3, 2018 China Biologic Announces Completion of Acquisition of TianXinFu from PWM Beijing, China—January 3, 2018— Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “We are pleased to welcome TianXinFu into the China Biologic family. We lo]
CBPO [China Biologic Products] 6-K: FOR RELEASE January 3, 2018 China Biologic Announces
[FOR RELEASE January 3, 2018 China Biologic Announces Completion of Acquisition of TianXinFu from PWM Beijing, China—January 3, 2018— Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, “We are pleased to welcome TianXinFu into the China Biologic family. We lo]
CBPO [China Biologic Products] 6-K: (Original Filing)
[AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT Amendment CBPO PWM Parties Party THIS AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT, dated as of December 29, 2017 (this “ RECITALS Share Exchange Agreement WHEREAS, the Parties have entered into the Share Exchange Agreement, dated as of October 12, 2017 (th]
CBPO [China Biologic Products] 6-K: AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT Amendment
[AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT Amendment CBPO PWM Parties Party THIS AMENDMENT NO. 1 TO SHARE EXCHANGE AGREEMENT, dated as of December 29, 2017 (this “ RECITALS Share Exchange Agreement WHEREAS, the Parties have entered into the Share Exchange Agreement, dated as of October 12, 2017 (th]
CBPO [China Biologic Products] 6-K: FOR RELEASE December 15, 2017 China Biologic Receives
[FOR RELEASE December 15, 2017 China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province BEIJING, China – December 15, 2017 – The Company announced the receipt of approval to build one new plasma collection station in Ju County and one branch collection ce]
CBPO [China Biologic Products] 6-K: (Original Filing)
[FOR RELEASE December 15, 2017 China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province BEIJING, China – December 15, 2017 – The Company announced the receipt of approval to build one new plasma collection station in Ju County and one branch collection ce]
